Real Life Data on OnabotulinumtoxinA for Treatment of Chronic Migraine in Pediatric Age

Real Life Data on OnabotulinumtoxinA for Treatment of Chronic Migraine in Pediatric Age

Background: The use of OnabotulinumtoxinA (OBT-A) for the treatment of chronic migraine (CM) in adults represents a therapy with the greatest efficacy and safety data. However, we have little evidence on the use of OBT-A in children or adolescents. The present study aims to describe the experience w...

Full description

Bibliographic Details
Main Authors: Laura Papetti, Ilaria Frattale, Fabiana Ursitti, Giorgia Sforza, Gabriele Monte, Michela Ada Noris Ferilli, Samuela Tarantino, Martina Proietti Checchi, Massimiliano Valeriani
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Journal of Clinical Medicine
Subjects:
OnabotulinumtoxinA
chronic migraine
adolescents
children
treatment
Online Access:https://www.mdpi.com/2077-0383/12/5/1802

Internet

https://www.mdpi.com/2077-0383/12/5/1802

Similar Items